The Pharma Data

DECEMBER 17, 2020

These follow-on data provided the first definitive prospective evidence demonstrating anti-viral activity for a treatment regimen now available for COVID-19, and also further documented the ability of this treatment to decrease the need for further medical attention,” said George D. Yancopoulos , M.D.,

Hospitals 52

Hospitals Production Clinical Trials Virus 52

The Pharma Data

DECEMBER 29, 2020

The benefit was driven by results starting one week post-treatment, when the risk of death or receiving mechanical ventilation was reduced by approximately half with antibody cocktail treatment, based on a post-hoc analysis. The results passed the futility analysis (p<0.3 Under an agreement with the U.S.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

The Pharma Data

AUGUST 3, 2020

Dame Anne Johnson, professor of infectious disease and epidemiology at University College London, told BBC Radio 4’s Today programme the new tests were “great news” but part of a wider system which needed to act rapidly overall. Good news – but breakthrough will be judged on results. Firstly, speed.

Government 52

Government DNA Hospitals Laboratories 52

The Pharma Data

FEBRUARY 1, 2021

1, 2021 — As America’s vaccination campaign begins to gain momentum, a promising sign has emerged: Federal data shows that coronavirus cases in nursing homes have declined over the past four weeks. The country recorded 17,584 cases in nursing homes during the week ending Jan. Centers for Disease Control and Prevention.

Nurses 52

Nurses Vaccine Long-Term Care Facilities Virus 52

The Pharma Data

DECEMBER 11, 2020

Health care workers and nursing home residents and staff should get the first shots, according to guidelines issued recently by the U.S. Centers for Disease Control and Prevention. “This disease progresses very quickly and can get very ugly very fast. Who is first in line?

Vaccine 52

Vaccine FDA Hospitals Doctors 52

PLOS: DNA Science

JUNE 1, 2023

The gene treatment has been a long time coming, but it differs from the handful of other approved gene therapies: it isn’t a one-and-done. Peter Marinkovich, MD, director of the Blistering Disease Clinic at Stanford Health Care, calls DEB a devastating disease. Earlier results were published in Nature Medicine.

FDA Approval 52

FDA Approval Therapies FDA Disease 52

The Pharma Data

SEPTEMBER 23, 2020

‘A scary time’ Clementine Stott, an organ donation specialist nurse at Worcester Royal Hospital, was redeployed to the intensive care unit during the first wave which, for her, meant separating from her 10-year-old son for seven weeks. “With the virus, we had to adapt to a totally different way of working,” she said.

Nurses 52

Nurses Hospitals Virus Government 52

The Pharma Data

JANUARY 26, 2021

While the preliminary nature of Phase 2 results from COVID-19 neutralizing monoclonal antibodies may have limited acceptance of treatment, these Phase 3 data further strengthen the available evidence,” said Daniel Skovronsky, M.D., Lilly’s chief scientific officer and president of Lilly Research Laboratories.

Hospitals 52

Hospitals Treatment Long-Term Care Facilities Trials 52

The Pharma Data

NOVEMBER 20, 2020

The casirivimab and imdevimab antibody cocktail is designed to mimic what a well-functioning immune system does by using very potent antibodies to neutralize the virus,” said George D. Food and Drug Administration (FDA). Yancopoulos, M.D., President and Chief Scientific Officer of Regeneron. Department of Health and Human Services.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

NOVEMBER 18, 2020

18, 2020 /PRNewswire/ — Tampa General Hospital provided the first monoclonal antibody treatment to a COVID-19 positive patient today. This single dose infusion-based treatment is provided on an outpatient basis and marks a dramatic shift in COVID-19 care. Currently receiving immunosuppressive treatment.

Hospitals 40

Hospitals Treatment Virus Nurses 40

The Pharma Data

NOVEMBER 21, 2020

21, 2020 /PRNewswire/ — First treatment of any kind to have prospectively confirmed and statistically significant anti-viral activity against SARS-CoV-2. ” “REGEN-COV2 is designed to mimic what a well-functioning immune system does by using very potent antibodies to neutralize the virus,” said George D.

FDA 40

FDA Clinical Trials Hospitals Government 40

The Pharma Data

JANUARY 24, 2021

It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. It will be run through the NIAID-supported Infectious Diseases Clinical Research Consortium (IDCRC), with support from the Bill & Melinda Gates Foundation. Non-COVID-19-Related. BT-001 is based on the patented Invir.IO

Long-Term Care Facilities 52

Long-Term Care Facilities Trials Virus Clinical Trials 52

PLOS: DNA Science

MARCH 30, 2023

. “What is different and particularly scary about Candida auris is that it can survive on skin and healthcare surfaces up to two weeks, allowing the spread from person-to-person in healthcare settings and nursing homes. Tick, tick, boom! It currently tops 15 million. It’s an old technique. The search is on for new antifungals.

DNA 52

DNA Hospitals Laboratories Virus 52

The Pharma Data

AUGUST 3, 2021

Food & Drug Administration (FDA) for Istodax ® (romidepsin), a histone deacetylase (HDAC) inhibitor, as monotherapy for the treatment of peripheral T-cell lymphoma (PTCL) in adult patients who have received at least one prior therapy. Bristol Myers Squibb is notifying healthcare professionals about the withdrawal. Indication.

Nurses 52

Nurses Clinical Trials Treatment Laboratories 52

The Pharma Data

DECEMBER 23, 2020

Moderna and other companies that have worked more closely with Operation Warp Speed to develop their vaccines already receive favored treatment from suppliers, the Times reported. ” Several infectious disease experts said Monday the variant may not have even originated in Britain, the Washington Post reported.

Vaccine 52

Vaccine Government Virus Medical Schools 52

The Pharma Data

JANUARY 22, 2021

“One of the new things in this administration is, if you don’t know the answer, don’t guess,” the nation’s top infectious disease expert said during a White House briefing on Thursday, the Associated Press reported. Antibody Drug Protects Nursing Home Residents, Staff From COVID-19.

Nurses 52

Nurses Vaccine Virus Science 52